Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

'Snowzilla' Delays Drug Price Hearing; Shkreli Travel OK'd

This article was originally published in Scrip

Executive Summary

A federal judge has given his OK for Martin Shkreli – the former Turing Pharmaceuticals Inc. CEO Americans love to hate and who has become despised among the big players in the biopharmaceutical industry – to travel to Washington to comply with a subpoena issued by lawmakers summoning him to a hearing on drug prices.